4369 Tri Chemical Laboratories Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4369

TSE Prime

Tri Chemical Laboratories Inc.

3,060

JPY

-70

(-2.24%)

Mar 13, 3:30 pm JST

19.19

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

3,000

Mar 14, 12:53 am JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2023	13,803	3,504	6,186	4,832	148.7	30	Mar 15, 2023	J-GAAP
Jan, 2024	11,246	1,947	3,276	2,470	76.0	30	Mar 15, 2024	J-GAAP
Jan, 2025	18,905	5,256	6,583	4,961	152.7	35	Mar 14, 2025	J-GAAP
Jan, 2026	23,883	5,902	7,090	5,515	169.7	35	Mar 13, 2026	J-GAAP
Jan, 2027 Guidance	27,000	6,000	6,300	4,600	141.6	35	Mar 13, 2026	J-GAAP
YoY	+13.1%	+1.7%	-11.1%	-16.6%	-16.6%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jan, 2022	Mar 15, 2021	10,700	2,700	4,400	3,470	17*	J-GAAP
	Aug 31, 2021	11,000	2,950	4,980	3,880	17*	J-GAAP
Results	Mar 15, 2022	11,574	2,976	5,294	4,095	20*	J-GAAP
Jan, 2023	Mar 15, 2022	Available in future release
	Aug 31, 2022
Results	Mar 15, 2023
Jan, 2024	Mar 15, 2023
	Aug 31, 2023
Results	Mar 15, 2024
Jan, 2025	Mar 15, 2024
	Aug 30, 2024
	Feb 14, 2025
Results	Mar 14, 2025
Jan, 2026	Mar 14, 2025
	Aug 29, 2025
Results	Mar 13, 2026
Jan, 2027	Mar 13, 2026	27,000	6,000	6,300	4,600	35	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan, 2003	1,816	－	Available in future release
Jan, 2004	1,789	-1.5
Jan, 2005	1,858	+3.9
Jan, 2006	2,089	+12.4
Jan, 2007	2,701	+29.3
Jan, 2008	3,601	+33.3
Jan, 2009	3,244	-9.9
Jan, 2010	2,397	-26.1
Jan, 2011	3,192	+33.2
Jan, 2012	4,015	+25.8
Jan, 2013	3,217	-19.9
Jan, 2014	3,361	+4.5
Jan, 2015	4,103	+22.1
Jan, 2016	4,956	+20.8
Jan, 2017	5,469	+10.4
Jan, 2018	6,445	+17.8
Jan, 2019	7,792	+20.9
Jan, 2020	8,267	+6.1
Jan, 2021	9,801	+18.6
Jan, 2022	11,574	+18.1
Jan, 2023	13,803	+19.3
Jan, 2024	11,246	-18.5
Jan, 2025	18,905	+68.1
Jan, 2026	23,883	+26.3
Jan, 2027 Guidance	27,000	+13.1	6,000	+1.7	6,300	-11.1	141.6	-16.6

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jan, 2025	18,905	5,256	27.8	16.77	14.42	0.55	152.7
Jan, 2026	23,883	5,902	24.7	16.28	13.10	0.57	169.7
Jan, 2027 Guidance	27,000	6,000	22.2	12.73	9.73	0.57	141.6

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	23,883	5,902	7,090	5,515	169.7
Fiscal Year	Jan, 2026	Jan, 2026	Jan, 2026	Jan, 2026	Jan, 2026

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb - Jul, 2023	5,622	1,100	1,906	1,453	44.7	0	Aug 31, 2023	J-GAAP
Feb - Jul, 2024	7,974	1,939	2,680	2,031	62.5	0	Aug 30, 2024	J-GAAP
Feb - Jul, 2025	12,375	3,177	3,800	2,776	85.5	0	Aug 29, 2025	J-GAAP
Feb - Jul, 2026 Guidance	13,700	2,960	3,090	2,190	67.4	0	Mar 13, 2026	J-GAAP
YoY	+10.7%	-6.8%	-18.7%	-21.1%	-21.1%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jul, 2023	Mar 15, 2023	7,100	1,620	2,410	1,870	0	J-GAAP
Results	Aug 31, 2023	5,622	1,100	1,906	1,453	0	J-GAAP
Jul, 2024	Mar 15, 2024	Available in future release
Results	Aug 30, 2024
Jul, 2025	Mar 14, 2025
Results	Aug 29, 2025
Jul, 2026	Mar 13, 2026	13,700	2,960	3,090	2,190	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jan, 2024	1,947	1,191	2,972	-1,781	-1,858	10,497	32.94	J-GAAP
Jan, 2025	5,256	559	3,675	-3,116	-1,620	9,439	25.55	J-GAAP
Jan, 2026	5,902	-3,259	3,795	-7,054	1,088	7,279	15.40	J-GAAP

Actual Performance and Financial Trends

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2024	11,246	1,947	3,276	2,470	76.0	30	Mar 15, 2024	J-GAAP
Jan, 2025	18,905	5,256	6,583	4,961	152.7	35	Mar 14, 2025	J-GAAP
Jan, 2026	23,883	5,902	7,090	5,515	169.7	35	Mar 13, 2026	J-GAAP
YoY	+26.3%	+12.3%	+7.7%	+11.2%	+11.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Feb - Apr, 2024	3,274	664	1,068	812	25.0	20.3	May 31, 2024	J-GAAP
May - Jul, 2024	4,700	1,275	1,612	1,219	37.5	27.1	Aug 30, 2024	J-GAAP
Aug - Oct, 2024	5,131	1,563	1,671	1,195	36.8	30.5	Nov 29, 2024	J-GAAP
Nov - Jan, 2024	5,800	1,754	2,232	1,735	53.4	30.2	Mar 14, 2025	J-GAAP
Feb - Apr, 2025	6,569	1,712	1,640	1,207	37.2	26.1	May 30, 2025	J-GAAP
May - Jul, 2025	5,806	1,465	2,160	1,569	48.3	25.2	Aug 29, 2025	J-GAAP
Aug - Oct, 2025	5,635	1,384	1,658	1,245	38.3	24.6	Nov 28, 2025	J-GAAP
Nov - Jan, 2025	5,873	1,341	1,632	1,494	46.0	22.8	Mar 13, 2026	J-GAAP
YoY	+1.3%	-23.5%	-26.9%	-13.9%	-13.9%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Feb - Apr, 2021	2,594	+13.4	Available in future release
May - Jul, 2021	2,773	+9.8
Aug - Oct, 2021	3,160	+25.0
Nov - Jan, 2021	3,047	+23.8
Feb - Apr, 2022	3,119	+20.2
May - Jul, 2022	3,429	+23.7
Aug - Oct, 2022	3,591	+13.6
Nov - Jan, 2022	3,664	+20.2
Feb - Apr, 2023	3,228	+3.5
May - Jul, 2023	2,394	-30.2
Aug - Oct, 2023	2,593	-27.8
Nov - Jan, 2023	3,031	-17.3
Feb - Apr, 2024	3,274	+1.4
May - Jul, 2024	4,700	+96.3
Aug - Oct, 2024	5,131	+97.9
Nov - Jan, 2024	5,800	+91.4
Feb - Apr, 2025	6,569	+100.6
May - Jul, 2025	5,806	+23.5
Aug - Oct, 2025	5,635	+9.8
Nov - Jan, 2025	5,873	+1.3	1,341	-23.5	1,632	-26.9	46.0	-13.9

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	6,569	1,754	2,232	1,735	53.4
Fiscal Year	Apr, 2025	Jan, 2024	Jan, 2024	Jan, 2024	Jan, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jan, 2024	848.40	86.5	31,864	27,570	20,304	0.09	Mar 15, 2024	J-GAAP
Jan, 2025	972.02	85.5	36,944	31,587	24,291	0.06	Mar 14, 2025	J-GAAP
Jan, 2026	1,112.41	76.5	47,274	36,149	28,669	0.11	Mar 13, 2026	J-GAAP

Tri Chemical Laboratories Inc.(4369) Financial Results